|
|
FDA expert panel in line with SciBase position to keep stringent approval level for all new skin lesion analyzers |
|
|
Annual general meeting has been held in SciBase Holding AB (publ) |
|
|
US study shows that EIS and Nevisense significantly improves clinicians' diagnostic accuracy |
|
|
Interim Report Q1 2022 |
|
|
SciBase to present at the Redeye Medtech & Diagnostics Seminar on May 11, 2022 |
|
|
German study shows clinical benefit of Nevisense |
|
|
SciBase publishes the Annual report for 2021 |
|
|
NOTICE TO ATTEND THE ANNUAL GENERAL MEETING IN SCIBASE HOLDING AB (PUBL) |
|
|
SciBase further strengthens patent portfolio |
|
|
SciBase Barrier technology part of major immunodermatology project |
